Literature DB >> 3810013

Lysophosphatidylcholine potentiates the increase in mucosal permeability after small-intestinal ischaemia.

T Otamiri, R Sjödahl, C Tagesson.   

Abstract

The influence of lysophosphatidylcholine (lysoPC), taurodeoxycholate (TDC), and taurochenodeoxycholate (TCDC) on the permeability properties of the ischaemic small-intestinal mucosa was investigated. We first studied the effect of ischaemia alone, then of lysoPC, TDC, or TCDC alone, and finally of ischaemia together with lysoPC, TDC, or TCDC on the permeability to sodium fluorescein in a ligated loop of the distal ileum in the rat. Longer periods of ischaemia alone (10 min or more) caused increased permeability, as did high concentrations (10 mM) of any of the agents. Low concentrations (1 mM) of lysoPC alone did not alter the gut permeability, but it significantly potentiated the increased permeability caused by 30 min of ischaemia. In contrast, 1 mM TDC or TCDC did not influence the permeability after 30 min of ischaemia. These findings imply that the ischaemic small intestine may be damaged by small amounts of lysoPC, with increased absorption of potentially pathogenic compounds as a possible consequence. They also point to the possibility that endogenously formed lysoPC may play a role in the mucosal damage and the increased permeability that occurs after small-intestinal ischaemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3810013     DOI: 10.3109/00365528608996433

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.

Authors:  Kajsa Kajander; Eveliina Myllyluoma; Sinikka Kyrönpalo; Martin Rasmussen; Pentti Sipponen; Ismo Mattila; Tuulikki Seppänen-Laakso; Heikki Vapaatalo; Matej Oresic; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

Review 2.  Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury.

Authors:  Emily Archer Slone; Sherry D Fleming
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

3.  Increased phospholipase A2 and decreased lysophospholipase activity in the small intestinal mucosa after ischaemia and revascularisation.

Authors:  T Otamiri; L Franzén; D Lindmark; C Tagesson
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

4.  Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults.

Authors:  Riina-A Kekkonen; Marko Sysi-Aho; Tuulikki Seppanen-Laakso; Ilkka Julkunen; Heikki Vapaatalo; Matej Oresic; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

5.  Quinacrine prevention of intestinal ischaemic mucosal damage is partly mediated through inhibition of intraluminal phospholipase A2.

Authors:  T Otamiri
Journal:  Agents Actions       Date:  1988-12

6.  Phospholipase A2 inhibition prevents mucosal damage associated with small intestinal ischaemia in rats.

Authors:  T Otamiri; M Lindahl; C Tagesson
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.